Business
Economy
Investing
Politics

Top Posts

Crypto Market Update: Bitcoin’s New High, Ethereum ETFs...

Top 5 Small-cap Pharma Stocks of 2025

Brien Lundin: Gold at New US$3,000 Floor, Silver...

Brunswick Exploration Consolidates Mirage Ownership

Westport Files Preliminary Short Form Base Shelf Prospectus...

Element79 Gold Corp Announces Corporate Update and Strategic...

OPINION — Goldenomics 103: Gold Protects and Performs

Editor’s Picks: Gold Tariff Threat Ends, Price Reacts...

Top 5 Canadian Mining Stocks This Week: Focus...

Bed Bath & Beyond relaunches with first store...

Business
Economy
Investing
Politics

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024

December 20, 2024

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post

Completion of Tranche 1 of the Placement

next post

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

You may also like

Flynn Gold

August 13, 2024

Hempalta

December 12, 2024

Canadian Investment Regulatory Organization Trade Resumption – PRIZ

July 19, 2025

Zodiac Gold: Advancing a District-scale West African Gold...

August 2, 2024

Sarama Completes A$2m Equity Placement and ASX Cleansing...

November 30, 2024

Zijin to Take on Precious Metals Streaming as...

May 28, 2025

New Seismic Studies Upgrade Raya Prospect

August 19, 2024

WOA Announces Board and Management Changes

August 13, 2024

Lode Gold Announces $350,000 Non-Brokered Financing

December 24, 2024

David Erfle: Silver Staging “Powerful” Breakout; Plus Gold...

July 2, 2025

Fill Out & Get More Relevant News

Your name
Your email

Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

Recent Posts

Crypto Market Update: Bitcoin’s New High, Ethereum ETFs Outpace Bitcoin 5-to-1
August 16, 2025
Top 5 Small-cap Pharma Stocks of 2025
August 16, 2025
Brien Lundin: Gold at New US$3,000 Floor, Silver Supply Crunch Coming
August 16, 2025
Brunswick Exploration Consolidates Mirage Ownership
August 16, 2025
Westport Files Preliminary Short Form Base Shelf Prospectus To Replace Expired Base Shelf Prospectus
August 16, 2025

banner ads

Categories

Business (817)
Economy (829)
Investing (2,633)
Politics (737)

Privacy Policy
Terms & Conditions

Disclaimer: smarttradeinsights.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 smarttradeinsights.com | All Rights Reserved